France
Founded in 2012, Wandercraft embodies a bold mission: to restore and enhance human mobility using groundbreaking robotics technology. Based in France, the company operates at the cutting edge of the Health Care, Medical Devices, and Robotics industries. Wandercraft’s pioneering innovations include the world’s first self-balancing exoskeleton, a technology that liberates individuals from reliance on crutches or walkers, enhancing their mobility and independence.
Key products include the Atalante X, used in over 100 hospitals worldwide, and Eve, an exoskeleton currently in U.S. clinical trials anticipated for release in 2026. Wandercraft also ventures beyond healthcare with Calvin-40, an industrial humanoid robot undertaking physically demanding tasks, already deployed with partners like the Renault Group.
With 30+ patents and a $75.00M Series D investment from Renault Group in June 2025, Wandercraft is poised for significant growth, characterized by its innovative technologies in the robotic rehabilitation and industrial sectors.
